Kalydeco.html

<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Kalydeco</title>
    <link rel="shortcut icon" href="images/testlogo.png" type="image/x-icon">
    <link rel="stylesheet" href="css.css">
    <style>
        body {
            background-color: rgba(196, 241, 255, 0.562);
        }
        .container {
            text-align: center;
            margin-left: 100px;
            margin-right:100px;
        }
        p {
            font-size: 22px; /* Adjust the font size as desired */
            font-style: italic;
            text-align: justify;
            text-justify: inter-word;
          }
          table {
         border-spacing: 30px;
          }
    </style>
</head>
<body>
    <center>
        <h1>Kalydeco</h1><br>
        <table>
            <tr>
                <td><img src="https://5.imimg.com/data5/SELLER/Default/2023/3/QU/BS/RY/156458741/kalydeco-ivacaftor--1000x1000.jpg" width="300px" height="200px"  alt=""></td>

            </tr>
        </table>
            <div class="container">
                    <p>Kalydeco is a brand name for the medication ivacaftor. It is primarily used in the treatment of cystic fibrosis (CF) in patients with specific genetic mutations. Kalydeco targets a specific defective protein called the cystic fibrosis transmembrane conductance regulator (CFTR) and helps improve its function.

                        Kalydeco tablets are typically available in different strengths, such as 150 mg or 250 mg. The tablets are usually round and film-coated for easy swallowing. The color, shape, and markings on the tablets may vary depending on the manufacturer and specific formulation
                        
                        .</p>
            </div>
    </center>
    
</body>
</html>